Literature DB >> 9261480

Histopathologic findings in drug-induced pemphigus.

M Landau1, S Brenner.   

Abstract

Drug-induced pemphigus represents a diagnostic challenge, as usually no clinical feature differentiates it from its idiopathic counterpart. It was suggested recently that some histologic features may assist in diagnosing drug-associated diseases. The purpose of the study was to determine whether the histologic criteria suggested in the literature are specific enough to arouse suspicion of drug-induced pemphigus. Biopsy specimens of drug-induced and idiopathic pemphigus were reviewed by five dermatologists with no clinical data available about the patients. The sections were assessed to the presence of spongiosis with eosinophils, vacuolar degeneration, and the degree of acantholysis and cleavage level. Using the suggested criteria, the reviewers were unable to confirm a diagnosis of drug-induced pemphigus. It is advisable to consider drug etiology in every case of newly diagnosed pemphigus based on clinical criteria an detailed drug consumption history, as histologic features do not differentiate between drug-associated and idiopathic disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261480     DOI: 10.1097/00000372-199708000-00017

Source DB:  PubMed          Journal:  Am J Dermatopathol        ISSN: 0193-1091            Impact factor:   1.533


  2 in total

1.  Biologic therapy-induced pemphigus.

Authors:  Marina Zoega Hayashida; Jhonatan Rafael Siqueira Pinheiro; Milvia Maria Simões E Silva Enokihara; Mônica Ribeiro de Azevedo Vasconcellos
Journal:  An Bras Dermatol       Date:  2017 Jul-Aug       Impact factor: 1.896

Review 2.  Adverse Immunologically Mediated Oral Mucosal Reactions to Systemic Medication: Lichenoid Tissue Reaction/Interface Dermatitis-Stomatitis, Autoimmune Vesiculobullous Disease, and IgE-Dependent and Immune Complex Reactions.

Authors:  R A G Khammissa; R Chandran; A Masilana; J Lemmer; L Feller
Journal:  J Immunol Res       Date:  2018-06-10       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.